Gut

Optimal use of rifaximin in diverticular disease of the colon: use less for use better

I would like to thank Dr Marlicz and colleagues for their interesting comment about the current use of rifaximin in the management of diverticulosis and diverticular disease.1 In particular, all their ...
gut.bmj

Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease

Departments of Internal Medicine (Division of Digestive Diseases), Pharmacology, and Molecular Physiology, Rush University Medical Center, Chicago, IL 60612, USA Correspondence to: Dr A Keshavarzian, ...
gut.bmj

Prospective study of liver dysfunction in pregnancy in Southwest Wales

Correspondence to: Dr J Kingham, Department of Gastroenterology, Singleton Hospital, Sketty, Swansea SA2 8QA, UK; jkingham{at}swansea-tr.wales.nhs.uk Background: Liver dysfunction in pregnancy has ...
gut.bmj

Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study

Department of Internal Medicine and Gastroenterology, University of Bologna, Italy Objective: Existing endoscopy-based data on gastro-oesophageal reflux disease (GORD) in the general population are ...
gut.bmj

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

4 Department of Hepatogastroenterology, Hopital Claude Huriez, CHRU Lille, France Correspondence to: Professor J-F Colombel Department of Hepato-Gastroenterology, Hopital Claude Huriez, CHRU de Lille, ...
gut.bmj

S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development

Correspondence to Professor Michelangelo Foti, Department of Cell Physiology and Metabolism, University of Geneva Faculty of Medicine, Geneve 1206, Switzerland; michelangelo.foti{at}unige.ch Objective ...
gut.bmj

Cholinergic effects on human gastric motility

a Gastroenterology Section, Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania, USA, b Nuclear Medicine Section, Department of Diagnostic Imaging, Temple University ...
gut.bmj

Roseburia inulinivorans increases muscle strength

Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...
Gut

Appearances can be deceiving: an ulcerated oesophageal lesion

An 82-year-old man with alcohol-related cirrhosis (Child-Pugh class B), complicated by portal hypertension and a history of partial gastrectomy with Billroth I reconstruction for duodenal ulcer ...
gut.bmj

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and ...

5 Servicio de Aparato Digestivo, Hospital Donostia, San Sebastian, Spain 6 Servicio de Aparato Digestivo Hospital La Fe, Valencia, Spain 7 Servicio de Aparato Digestivo, Hospital de Asturias, Oviedo, ...
Gut

Are the drugs already on the shelf? Repurposing therapy for pancreatitis

The persistent absence of disease-modifying therapy for recurrent acute pancreatitis (RAP) and chronic pancreatitis (CP) represents one of the more conspicuous therapeutic gaps in gastroenterology.
Gut

Impairment of Rab7-dependent STING degradation hampers HBV replication but accelerates disease progression in chronic hepatitis B comorbid with MASLD

Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic hepatitis B (CHB), yet its impact on liver-related outcomes remains ...